How Dkk1 Affects Breast Cancer Stem Cells
Author Information
Author(s): Zvia Agur, Oleg U. Kirnasovsky, Genadiy Vasserman, Lilach Tencer-Hershkowicz, Yuri Kogan, Hannah Harrison, Rebecca Lamb, Robert B. Clarke
Primary Institution: Institute for Medical BioMathematics, Bene Ataroth, Israel; Breast Biology Group, School of Cancer and Enabling Sciences, Paterson Institute for Cancer Research, University of Manchester, Manchester, United Kingdom
Hypothesis
Can Dkk1 regulate the fate decisions of breast cancer stem cells through a mathematical model?
Conclusion
Dkk1 treatment can effectively drive breast cancer stem cells towards differentiation, but low doses may inadvertently promote their proliferation.
Supporting Evidence
- Dkk1 treatment reduced mammosphere formation in breast cancer cells at high concentrations.
- Low doses of Dkk1 did not significantly affect mammosphere formation in primary breast cancer cells.
- The mathematical model predicted a biphasic response to Dkk1 concentrations.
Takeaway
Dkk1 is like a switch for breast cancer stem cells, helping them decide whether to grow or change into different types of cells, but using too little can make them grow more.
Methodology
A multi-scale mathematical model was developed and validated through experiments on MCF-7 cells and primary breast cancer cells.
Potential Biases
Potential biases in the experimental setup and sample selection could affect the results.
Limitations
The study's findings may not fully translate to in vivo conditions and require further validation in animal models.
Participant Demographics
Breast cancer patients, specifically those with estrogen receptor-positive tumors.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website